Thursday saw David Sefton, a well-know figure on AIM, extend his portfolio of executive and non-executive positions by joining the board of Rose Petroleum (LSE:ROSE). Sefton, perhaps best known as...
WDC
Widecells launches Cellplan insurance product in Spain: A look at the potential upside case (WDC)
On Monday Widecells Group (LSE:WDC) announced the full launch of its Cellplan insurance product in Spain, providing cover for cord blood stem cell transplants. We have discussed the company’s...
Widecells hugely oversold and under recent placing price (WDC)
Widecells Group (LSE:WDC) has seen its share price slip below the recent placing price of 3p. We have covered the company before highlighting the potential upside the story offers to investors...
‘We have now cracked the model’: Widecells’ boss on global expansion plans and the growth of stem cell therapy (WDC)
Stem cell services company WideCells (LSE:WDC) is preparing to launch itself into a period of global expansion. With shares currently priced at 3p, the next six months could be very exciting even if...
WideCells Group signs landmark deal to distribute stem cell insurance in Asia (WDC)
WideCells Group (LSE:WDC) has signed a landmark deal that will see its stem cell insurance product, CellPlan, sold in Asia. The business has signed the deal with Cryoviva Group, an established cord...
WideCells offers landmark stem cell cover to open up booming market- can it turn this into profit? (WDC)
More than four million people around the world have stored away stem cell-rich umbilical cord blood samples that can potentially be used by both them and their families in future medical treatments....